Diseases, Conditions, Syndromes

First dengue vaccine goes on sale in Guatemala

The world's first vaccine against dengue, a mosquito-borne virus that causes fever and pain and can be fatal, will go on sale in Guatemala within weeks, the French company making it said Tuesday.

Diabetes

Sanofi, Medtronic join on diabetes drugs, devices

French drugmaker Sanofi and U.S. medical device manufacturer Medtronic Inc. have joined in a project to develop new combinations of drugs and devices for diabetes care.

Vaccination

France's Sanofi to seek COVID vaccine approval after delays

French pharmaceuticals giant Sanofi said Wednesday that its COVID-19 vaccine, developed with Britain's GSK, had delivered positive results after nearly a year of delays left it lagging far behind its rivals.

Vaccination

EU watchdog backs Sanofi COVID booster jab

The EU on Thursday approved a COVID booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.

Medications

US approves Sanofi, Regeneron arthritis drug

US federal regulators have given the green light to French pharmaceutical company Sanofi and its US partner Regeneron to market a drug to treat the chronic inflammatory condition, rheumatoid arthritis.

Vaccination

Sanofi, GSK launch final phase of Covid vaccine trials

French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated COVID vaccine as they race to add their jab to the world's arsenal against the pandemic.

Diseases, Conditions, Syndromes

Dengue vaccine to be tested in India

French health care giant Sanofi Pasteur will soon test a vaccine against dengue fever in India amid concerns about the increasingly global spread of the disease, reports said Monday.

Vaccination

France's Sanofi to invest 2 billion euros in mRNA vaccines

French pharmaceutical giant Sanofi said Tuesday that it would invest 2 billion euros ($2.4 billion) in the mRNA vaccine technology behind the pioneering Covid-19 jabs developed by rivals BioNTech-Pfizer and Moderna.

page 6 from 13